Life-Expectancy Gap Narrowing for HIV-Infected vs. Noninfected

But even for healthy HIV-infected persons starting early treatment, life expectancy by 2011 was still 5.7 years shorter than for uninfected controls.

Studies have shown that the survival gap between HIV-infected persons receiving antiretroviral therapy (ART) and noninfected persons has narrowed in recent years. However, the characteristics of the control groups for such comparisons often were not ideal.

Investigators have now analyzed data for 25,768 HIV-infected and 257,600 uninfected individuals (matched 1:10 by age, gender, medical center, and initial year of follow-up) in a large healthcare system to compare life expectancies between the two groups. The mean age of all individuals was 40, and 90% were men. The HIV-infected population more frequently had a history of smoking (45% vs. 31%), drug or alcohol abuse (21% vs. 9%), and hepatitis B or C infection (12% vs. 2%). For the HIV-posi…

Reviewing Author

Keith Henry, MD

Disclosures

Consultant/Advisory BoardViiV Advisory Board

Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes

Keith Henry, MD

Disclosures

Consultant/Advisory BoardViiV Advisory Board

Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes

Life-Expectancy Gap Narrowing for HIV-Infected vs. Noninfected

Topics

Reviewing Author